Decreased Plasma levels of active glucagon-like peptide-1 in coronary artery disease

Journal of the American College of Cardiology

Volumn 65, Issue 7, 2015, Pages 754-755

  Akiyama, Eiichi ^a   Sugiyama, Seigo ^a   Matsubara, Junichi ^a   Kurokawa, Hirofumi ^a   Konishi, Masaaki ^a   Nozaki, Toshimitsu ^a   Ohba, Keisuke ^a   Fujisue, Kouichirou ^a   Maeda, Hirofumi ^a   Sakamoto, Kenji ^a   Sugamura, Koichi ^a   Sumida, Hitoshi ^a   Jinnouchi, Hideaki ^a   Sakamaki, Kentaro ^a   Morita, Satoshi ^a   Kimura, Kazuo ^a   Umemura, Satoshi ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

AGED; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LETTER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; SYNTAX SCORE; BLOOD; CASE CONTROL STUDY; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PATHOLOGY;

AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED;

EID: 84922771067     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.11.043     Document Type: Letter

References (3)

1. J.J. Holst, C.F. Deacon, T. Vilsboll, T. Krarup, and S. Madsbad Glucagon-like peptide-1, glucose homeostasis and diabetes Trends Mol Med 14 2008 161 168
2. J. Matsubara, S. Sugiyama, and K. Sugamura A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein e-deficient mice J Am Coll Cardiol 59 2012 265 276
3. B.M. Scirica, D.L. Bhatt, and E. Braunwald Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 2013 1317 1326